Sort by
Investigating The Relationship Between The Mean Heart Doses Received In Left Breast Cancer Radiation Therapy With Pro-BNP And Troponin Values And Left Ventricular Systolic Function Based On Left Ventricle Ejection Fraction (LVEF) And Global Longitudinal Strain (GLS) Values In Echocardiography

Abstract BACKGROUND: The purpose of this study is to investigate the relationship between the mean heart dose received in left breast cancer radiation therapy and cardiac injury as measured by Pro-BNP and Troponin laboratory levels and left ventricular systolic function, as measured by LVEF and GLS levels in echocardiography. METHOD: This research was carried out at Omid Hospital, Isfahan City, Iran, using the before and after intervention study and single-arm approach on a population of patients diagnosed with cancer of the left breast who received radiation therapy for the left breast between 2021- 2022. Troponin, Pro-BNP, GLS, and LVEF were investigated before and after intervention. The data was analyzed using the t-test and the Mann-Whitney U test. Ultimately, it was examined using version 22 of the SPSS program. RESULTS: This study showed a statistically significant difference in pro-BNP before and after the intervention (P<0.001). Also, we investigated the relationship between the mean heart dose, mean LAD dose, mean LV dose, radiotherapy protocol, and V25 index with the changes of Troponin, Pro-BNP, GLS, and LVEF, and we observed no statistically significant relationship between them (P>0.05). CONCLUSION: Left breast radiation therapy does not affect cardiac factors like LVEF and troponin in the short term. Also, we observed Pro-BNP meaningful changes and the effect of V25 on GLS after the radiation. Studies with a larger sample size and a longer follow-up period are suggested.

Open Access
Relevant
The comparison of eight-week high-intensity interval training VS. moderate-intensity continuous training on inflammatory and metabolic biomarkers in type II diabetes: a pilot randomized controlled trial

Abstract Purpose: Low-grade chronic inflammation has been linked with several health complications like type II diabetes. Given that exercise potentially has anti-inflammatory effects, this study was designed to compare the impact of 8-week high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) on specific inflammatory and metabolic markers among a group of diabetic patients to examine how the intensity of exercise influences inflammation-related biomarkers. Methods: An open-labeled, parallel, randomized, controlled trial was conducted at a cardiovascular center. Twenty-seven participants (15 females, mean age: 51±6.2years, BMI: 29.4±3.9kg/m2) were allocated into three equal groups (n=9): HIIT, MICT, and control (CON). Blood samples were collected at baseline, 24 and 72 hours after the last training session. Plasma levels of calprotectin, myeloperoxidase (MPO), interleukin 6 (IL-6) (primary endpoints), and insulin were measured. Results: Comparing the data over time, none of the biomarkers showed significant differences between the study groups. IL-6 decreased over time in both training groups similarly (p˂0.001). Despite small improvements in anthropometric measures and maximal oxygen consumption (VO2max) among training groups compared to the CON group, the two training protocols had almost similar impacts on the investigated inflammatory and metabolic markers. Conclusions Our findings indicate no statistically significant difference in inflammatory and metabolic measures between the two training groups, so neither of the training protocols is superior. However, both training groups exhibited improvements compared to the control group in glucose, triglyceride, and waist-to-hip ratio. Trial registration: IRCT20181129041797N1 (date: 25 Dec. 2108). The full protocol of our study is also available on www.irct.ir

Open Access
Relevant
Increased prevalence of thyroid dysfunction in Tehran – HAMRAH study

BackgroundThe aim of the current study is to assess the prevalence of different categories of thyroid dysfunction and their associated risk factors among the modern urban population of Tehran, the capital of Iran.MethodsThe present investigation is a sub-study of the HAMRAH study, a population-based prospective study designed to assess the prevalence of traditional cardiovascular risk factors and their changes through a 10-year follow-up. 2228 (61% female) adults aged between 30 and 75 years old and with no overt cardiovascular diseases were selected through a multistage cluster randomized sampling. Blood levels of thyroid-stimulating hormone (TSH), thyroxin (T4), and triiodothyronine (T3) were measured with the aim of assessing the prevalence of abnormal thyroid function status among the modern urban Iranian population, and in order to report the total prevalence of participants with clinical hypo- or hyperthyroidism, the number of individuals taking thyroid-related drugs were added to the ones with overt thyroid dysfunction. A subgroup analysis was also performed to determine the associated risk factors of thyroid dysfunction.ResultsThe prevalence of thyroid dysfunction among the total population was 7% (95%CI: 5.9 − 8%) and 0.4% (95% CI: 0.1 − 0.6%) for subclinical and overt hypothyroidism, and 1.6% (95% CI: 1 − 2%) and 0.2% (95% CI: 0 − 0.3%) for subclinical and overt hyperthyroidism, respectively. Clinical thyroid dysfunction was detected in 10.3% of the study population (9.4% had clinical hypo- and 0.9% had clinical hyperthyroidism). In the subgroup analysis, thyroid dysfunction was significantly more prevalent among the female participants (P-value = 0.029).ConclusionsIn the current study, the prevalence of different categories of abnormal thyroid status, and also the rate of clinical hypo- and hyperthyroidism was assessed using the data collected from the first phase of the HAMRAH Study. In this study, we detected a higher prevalence of clinical and subclinical hypothyroidism among the Iranian population compared to the previous studies.

Open Access
Relevant